TRIB missed EPS expectations by 7.69%
Aug 21, 2024, 9:32 AM
0.00%
What does TRIB do
Trinity Biotech Plc, based in Bray, Wicklow, develops and markets diagnostic products for autoimmune, infectious diseases, and diabetes, serving both clinical laboratories and point-of-care segments. The company operates globally, providing raw materials to life sciences, owning brands like Uni-Gold and ImmuBlot, and runs a specialized reference laboratory.
Trinity Biotech Plc (TRIB) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Trinity Biotech Plc's actual EPS was -$0.71, missing the estimate of -$0.66 per share, resulting in a -7.69% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.